BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 19884690)

  • 1. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of tuberculosis in people living with HIV.
    Granich R; Akolo C; Gunneberg C; Getahun H; Williams P; Williams B
    Clin Infect Dis; 2010 May; 50 Suppl 3():S215-22. PubMed ID: 20397951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
    Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned.
    Howard AA; El-Sadr WM
    Clin Infect Dis; 2010 May; 50 Suppl 3():S238-44. PubMed ID: 20397954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.
    Lawn SD; Ayles H; Egwaga S; Williams B; Mukadi YD; Santos Filho ED; Godfrey-Faussett P; Granich RM; Harries AD
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):287-95. PubMed ID: 21333094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
    Maher D; Harries A; Getahun H
    Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD; Zachariah R; Lawn SD
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
    Marais BJ; Graham SM; Cotton MF; Beyers N
    J Infect Dis; 2007 Aug; 196 Suppl 1():S76-85. PubMed ID: 17624829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.
    von Reyn CF; Bakari M; Arbeit RD; Lahey T; Ramadhani A; Egwaga S
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):718-23. PubMed ID: 22507085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated tuberculosis: diagnostic and treatment challenges.
    El-Sadr WM; Tsiouris SJ
    Semin Respir Crit Care Med; 2008 Oct; 29(5):525-31. PubMed ID: 18810685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection-related tuberculosis: clinical manifestations and treatment.
    Sterling TR; Pham PA; Chaisson RE
    Clin Infect Dis; 2010 May; 50 Suppl 3():S223-30. PubMed ID: 20397952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The current and future situations of TB/HIV (co-infection of tuberculosis and HIV) in Japan].
    Yamada N; Nagai H
    Kekkaku; 2009 Apr; 84(4):203-11. PubMed ID: 19425395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis in HIV-infected patients: a comprehensive review.
    Aaron L; Saadoun D; Calatroni I; Launay O; Mémain N; Vincent V; Marchal G; Dupont B; Bouchaud O; Valeyre D; Lortholary O
    Clin Microbiol Infect; 2004 May; 10(5):388-98. PubMed ID: 15113314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Control of tuberculosis in relation to the HIV/AIDS epidemic. Work Group at the Secretariat of the National Plan on AIDS].
    Rev Esp Salud Publica; 1999; 73(5):533-47. PubMed ID: 10650745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.